Tesamorelin + Ipamorelin
GHRH plus selective GHRP dual approach driving pulsatile GH release, with focus on visceral adiposity reduction.
Fat loss intermediate 8-16 weeks on, 4-8 weeks off
24-hour timeline
0:00 6:00 12:00 18:00 24:00
- Tesamorelin
- Ipamorelin
Protocol
Once daily SubQ injection, ideally at bedtime to follow natural nocturnal GH pulse. Balanced 5/5 vial example: reconstitute to draw 167 mcg of each per 10 units. Weeks 1-2 at 167 mcg + 167 mcg (10 units), weeks 3-4 at 333 mcg + 333 mcg (20 units), weeks 5-8 at 500 mcg + 500 mcg (30 units), weeks 9-16 at 667 mcg + 667 mcg (40 units). Alternative GHRH-dominant 10/3 vial: 333 mcg tesamorelin + 100 mcg ipamorelin per 30-unit draw.